首页|脾多肽联合乙酰半胱氨酸对重症肺部感染老年患者的治疗效果分析

脾多肽联合乙酰半胱氨酸对重症肺部感染老年患者的治疗效果分析

扫码查看
目的 探讨脾多肽联合乙酰半胱氨酸对重症肺部感染老年患者的治疗效果。方法 选择 2021 年 1 月至 2023年 12 月睢县人民医院接诊的重症肺部感染老年患者 86 人作为研究对象,依据随机数字表分为对照组(n=43)、观察组(n=43)。两组均接受常规治疗,对照组在此基础上采用乙酰半胱氨酸雾化吸入,观察组采用乙酰半胱氨酸雾化吸入联合脾多肽注射液滴注治疗。对比两组治疗前、后的相关临床指标:肺功能指标(动脉血氧分压、动脉血二氧化碳分压、氧合指数)、呼吸动力参数(气道阻力,峰值吸气压力,平均气道压力)、血清应激指标(血清游离皮质醇,促肾上腺皮质激素)。对比两组的症状持续时间、机械通气时间、治疗效果以及严重不良反应情况。结果 治疗后,观察组动脉血氧分压、氧合指数、峰值吸气压力高于对照组,观察组动脉血二氧化碳分压、气道阻力、平均气道压力、血清游离皮质醇、促肾上腺皮质激素低于对照组,差异均有统计学意义(P<0。05)。观察组发热、咳嗽、呼吸急促的持续时间、机械通气的时间短于对照组,差异均有统计学意义(P<0。05)。观察组治疗效果分级优于对照组,差异具有统计学意义(P<0。05)。两组均未产生严重不良反应。结论 针对重症肺部感染老年患者,在常规治疗措施的基础上,联合使用脾多肽静脉滴注及乙酰半胱氨酸雾化吸入,可以有效改善患者的治疗效果以及多个维度的临床指标,缩短患者的临床症状维持时间长度及使用机械通气时间,具有良好的安全性。
Effect Analysis of Spleen Polypeptide Combined with Acetylcysteine in Treatment of Elderly Patients with Severe Pulmonary Infection
Objective To investigate the therapeutic effect of spleen polypeptide combined with acetylcysteine on elderly patients with severe pulmonary infection.Methods A total of 86 elderly patients with severe pulmonary infection admitted to Suixian People's Hospital from January 2021 to December 2023 were selected as study subjects and divided into control group(n=43)and observation group(n=43)according to a random number table.Both groups received conventional treatment,the control group was given atomized acetyl cysteine inhalation on this basis,and the observation group was given atomized acetyl cysteine inhalation combined with spleen polypeptide injection.The relevant clinical indicators of the two groups were compared before and after treatment:pulmonary function indicators(arterial partial pressure of oxygen,arterial partial pressure of carbon dioxide,oxygenation index),respiratory dynamic parameters(airway resistance,peak inspiratory pressure,mean airway pressure),serum stress indicators(serum free cortisol,adrenocorticotropin).Symptom duration,mechanical ventilation time,therapeutic effect and severe adverse reactions were compared between the two groups.Results After treatment,the partial blood oxygen pressure,oxygenation index and peak inspiratory pressure in observation group were higher than those in control group,while the partial blood carbon dioxide pressure,airway resistance,mean airway pressure,serum free cortisol and adrenocorticotropic hormone in observation group were lower than those in control group,and the differences were statistically significant(P<0.05).The duration of fever,cough,tachypnea and mechanical ventilation in observation group were shorter than those in control group,and the differences were statistically significant(P<0.05).The treatment effect grading of the observation group was better than that of control group,and the difference was statistically significant(P<0.05).There were no serious adverse reactions in both groups.Conclusion For elderly patients with severe pulmonary infection,on the basis of conventional treatment,the combination of spleen polypeptide intravenous infusion and acetyl cysteine aerosol inhalation can effectively improve the therapeutic effect and clinical indicators of multiple dimensions,shorten the maintenance time of clinical symptoms and the use of mechanical ventilation,with good safety.

spleen polypeptideacetylcysteinesevere pulmonary infectionthe elderlylung functionblood oxygen partial pressure

马高峰

展开 >

睢县人民医院 呼吸与危重症医学科,河南 商丘 476900

脾多肽 乙酰半胱氨酸 重症肺部感染 老年人 肺功能 血氧分压

2024

临床研究
西安交通大学

临床研究

影响因子:0.234
ISSN:2096-1278
年,卷(期):2024.32(5)
  • 23